Literature DB >> 8388166

Acute promyelocytic leukemia with the pseudo-Chediak-Higashi anomaly and molecular documentation of t(15;17) chromosomal translocation.

P H Symes1, M E Williams, H C Flessa, A K Srivastava, S H Swerdlow.   

Abstract

Two morphologic variants of acute promyelocytic leukemia (AML M3) are recognized--the hypergranular form, in which Auer rods are usually numerous; and the microgranular form. The case of AML M3 reported here lacked numerous Auer rods but was hypergranular and demonstrated prominent giant Chediak-Higashi-like granules in the leukemic cells. Although routine karyotypic studies were inconclusive, at t(15;17) translocation was documented using Southern blot genotypic analysis and probes for the retinoic acid receptor-alpha and pml genes. This is the first case of this unusual morphologic anomaly in which the granules are described in routine histologic sections and the first with evidence of a t(15;17) chromosomal translocation. It also illustrates the importance of Southern blot analysis in suspected cases of AML M3 with "negative" karyotypic studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388166     DOI: 10.1093/ajcp/99.5.622

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Ratio of bcl-xshort to bcl-xlong is different in good- and poor-prognosis subsets of acute myeloid leukemia.

Authors:  G Deng; C Lane; S Kornblau; A Goodacre; V Snell; M Andreeff; A B Deisseroth
Journal:  Mol Med       Date:  1998-03       Impact factor: 6.354

2.  Pseudo chediak-higashi granules in acute lymphoblastic leukemia: a rare entity.

Authors:  Pallavi Agrawal; Narender Kumar; Prashant Sharma; Subhash Varma; Neelam Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-06       Impact factor: 0.900

3.  Pseudo chediak-higashi anomaly.

Authors:  Zekai Avcı; Barış Malbora; Namık Ozbek
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.